吉隆坡消息:乙型肝炎疫苗与乙型肝炎免疫球蛋白(HBIG)合用,对HBeAg阳性妇女所生婴儿作免疫注射,可预防婴儿为HBeAg携带者。如按通常预防方法免疫新生儿,失败率肯定为5%至10%。但是据台湾大学附属医院儿科的C Y Lee及其同事称,一种加强预防方案可能明显减少失败率。由于失败病例是指抗原血出现于生后3～6个月,以及在疫苗接 KUALA LUMPUR: Hepatitis B vaccine, in combination with hepatitis B immunoglobulin (HBIG), is immunized against infants born to HBeAg-positive women to prevent babies from becoming HBeAg carriers. If immunizations of newborns are based on the usual precautionary measures, the failure rate will certainly be 5% to 10%. However, according to C Y Lee and colleagues at the National Taiwan University Hospital Pediatrics, an enhanced prevention program may significantly reduce the failure rate. Because of the failure of the case is that antigen blood appeared in 3 to 6 months after birth, as well as in the vaccine